ONKURE THERAPEUTICS, INC. Unrecognized Tax Benefits that Would Impact Effective Tax Rate
ONKURE THERAPEUTICS, INC. (OKUR) had Unrecognized Tax Benefits that Would Impact Effective Tax Rate of $11.00 million as of 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate · last filed 2024-03-28
- 2023-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $11.00M.
- 2022-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $7.10M.
- 2021-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $3.00M.
| Period end | Unrecognized Tax Benefits that Would Impact Effective Tax Rate |
|---|---|
| 2023-12-31 | $11.00M 10-K · filed 2024-03-28 |
| 2022-12-31 | $7.10M 10-K · filed 2023-03-27 |
| 2021-12-31 | $3.00M 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |